Enanta Pharmaceuticals | ENTA - Ebit





Ebit Changement Date
AbbVie USD 6.72B 1.99B 2026-06
Amgen USD 4.61B 777M 2026-06
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -154.34M 13.08M 2026-06
AstraZeneca USD 3.16B 3.95B 2026-06
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
Biogen USD -243.8M 758.1M 2026-06
Bristol-Myers Squibb USD 299M 3.26B 2026-06
Enanta Pharmaceuticals USD -23.54M 6.31M 2024-12
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
Halozyme Therapeutics USD -63.72M 1.95M 2026-06
Heron Therapeutics USD 38K 3.83M 2025-12
Immunic USD -23.33M 2.67M 2025-12
Incyte USD 700.4M 356.23M 2026-06
Insmed USD -101.31M 98.97M 2026-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
J&J USD 7.48B 860M 2026-06
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Ligand Pharmaceuticals USD 56.62M 3.7M 2026-06
Merck USD 840M 2.72B 2026-06
Neurocrine Biosciences USD 219.9M 5.3M 2026-06
Novartis USD 4.73B 549M 2026-06
Novavax USD 20.94M 100.32M 2025-12
Pfizer USD -180M 5.16B 2026-06
PTC Therapeutics USD 45.89M 127.51M 2026-03
Roche Holding CHF 11.46B 1.91B 2026-06
Sarepta Therapeutics USD 13.29M 345.14M 2026-06
Vertex Pharmaceuticals USD 1.27B 129.9M 2026-06